Vaccination strategies for patients under monoclonal antibody and other biological treatments: an updated comprehensive review based on EMA authorisations to January 2024
Sign Up to like & getrecommendations! Published in 2024 at "Expert Review of Vaccines"
DOI: 10.1080/14760584.2024.2401839
Abstract: ABSTRACT Introduction Monoclonal antibodies (mAbs) and other biological agents are being increasingly approved in the last years with very different indications. Their highly heterogeneous immunosuppressive effects, mechanisms of action and pharmacokinetics require comprehensive individualized vaccination… read more here.
Keywords: biological treatments; review; vaccination strategies; january 2024 ... See more keywords
Early COVID‐19 XBB.1.5 Vaccine Effectiveness Against Hospitalisation Among Adults Targeted for Vaccination, VEBIS Hospital Network, Europe, October 2023–January 2024
Sign Up to like & getrecommendations! Published in 2024 at "Influenza and Other Respiratory Viruses"
DOI: 10.1111/irv.13360
Abstract: We conducted a multicentre test‐negative case–control study covering the period from October 2023 to January 2024 among adult patients aged ≥ 18 years hospitalised with severe acute respiratory infection in Europe. We provide early estimates of the… read more here.
Keywords: october 2023; vaccine effectiveness; january 2024; vaccination ... See more keywords
Introducing researchers involved in vector control to modelling for operational decision-making in Benin: report of the workshop, January 17–18, 2024
Sign Up to like & getrecommendations! Published in 2025 at "Malaria Journal"
DOI: 10.1186/s12936-025-05561-w
Abstract: Malaria continues to pose a major threat despite numerous efforts aimed at reducing its incidence and ultimately eliminating the disease. The majority of malaria cases occur in Africa. According to the World Health Organization, one… read more here.
Keywords: report; control; decision making; january 2024 ... See more keywords